163155-63-3

Upstream product

• 163155-61-1 (3,4-Dihydro-2H-benzo[1,4]thiazin-5-yl)-(2-fluoro-phenyl)-methanone 
• 3080-99-7 3,4-dihydro-2H-benzo[1,4]thiazine 
• 394-47-8 2-fluorobenzonitrile 
• 163155-62-2 2-Bromo-1-[5-(2-fluoro-benzoyl)-2,3-dihydro-benzo[1,4]thiazin-4-yl]-ethanone 

Downstream Products

• 163155-65-5 Methanesulfonic acid 7-(2-fluoro-phenyl)-10-oxo-1,2,9,10-tetrahydro-3-thia-8,10a-diaza-cyclohepta[de]naphthalen-9-yl ester 
• 167645-16-1 9-Amino-7-(2-fluoro-phenyl)-1,2-dihydro-9H-3-thia-8,10a-diaza-cyclohepta[de]naphthalen-10-one 
• 167645-11-6 7-(2-Fluoro-phenyl)-9-hydroxy-1,2-dihydro-9H-3-thia-8,10a-diaza-cyclohepta[de]naphthalen-10-one 

Relevant academic research and scientific papers

Studies on a novel, potent and orally effective cholecystokinin A antagonist, FK-480. Synthesis and structure-activity relationships of FK-480 and related compounds

We prepared various novel tricyclic 1,4-benzodiazepine derivatives as cholecystokinin (CCK) A antagonists, which were evaluated preliminarily for inhibition of 125I-CCK-8 binding to rat pancreatic membranes in vitro and inhibiting effect on CCK